Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers

View ORCID ProfileRocio Eiros, View ORCID ProfileManuel Barreiro-Perez, Ana Martin-Garcia, Julia Almeida, View ORCID ProfileEduardo Villacorta, View ORCID ProfileAlba Perez-Pons, Soraya Merchan, View ORCID ProfileAlba Torres-Valle, View ORCID ProfileClara Sánchez Pablo, View ORCID ProfileDavid González-Calle, View ORCID ProfileOihane Perez-Escurza, Inés Toranzo, Elena Díaz-Pelaez, View ORCID ProfileBlanca Fuentes-Herrero, Laura Macías-Alvarez, Guillermo Oliva-Ariza, Quentin Lecrevisse, Rafael Fluxa, Jose L Bravo-Grande, View ORCID ProfileAlberto Orfao, View ORCID ProfilePedro L Sanchez
doi: https://doi.org/10.1101/2020.07.12.20151316
Rocio Eiros
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rocio Eiros
Manuel Barreiro-Perez
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manuel Barreiro-Perez
Ana Martin-Garcia
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Almeida
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Villacorta
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eduardo Villacorta
Alba Perez-Pons
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
MScM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alba Perez-Pons
Soraya Merchan
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alba Torres-Valle
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alba Torres-Valle
Clara Sánchez Pablo
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
Nr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clara Sánchez Pablo
David González-Calle
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David González-Calle
Oihane Perez-Escurza
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oihane Perez-Escurza
Inés Toranzo
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Díaz-Pelaez
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blanca Fuentes-Herrero
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Blanca Fuentes-Herrero
Laura Macías-Alvarez
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo Oliva-Ariza
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quentin Lecrevisse
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
Eng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafael Fluxa
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
Eng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose L Bravo-Grande
3Occupational Health Service, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, Salamanca, SPAIN
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Orfao
2Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca, Cytometry Service, NUCLEUS, IBSAL, and CIBERONC, Salamanca. SPAIN
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Orfao
Pedro L Sanchez
1Cardiology Department, University Hospital of Salamanca, IBSAL, Faculty of Medicine, University of Salamanca, and CIBERCV (ISCiii), Salamanca, SPAIN
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pedro L Sanchez
  • For correspondence: pedrolsanchez{at}secardiologia.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Cardiac sequelae of past SARS-CoV-2 infection are still poorly documented. We conducted a cross-sectional study in health-care workers to report evidence of pericarditis and myocarditis after SARS-CoV-2 infection.

Methods We studied 139 health-care workers with confirmed past SARS-CoV-2 infection (103 diagnosed by RT-PCR and 36 by serology). Participants underwent clinical assessment, electrocardiography, laboratory tests including immune cell profiling and cardiac magnetic resonance (CMR). Pericarditis was diagnosed when classical criteria were present, and the diagnosis of myocarditis was based on the updated CMR Lake-Louise-Criteria.

Results Median age was 52 years (IQR 41–57), 100 (72%) were women, and 23 (16%) were previously hospitalized for Covid-19 pneumonia. At examination (10.4 [9.3–11.0] weeks after infection-like symptoms), all participants presented hemodynamic stability. Chest pain, dyspnoea or palpitations were observed in 58 (42%) participants; electrocardiographic abnormalities in 69 (50%); NT-pro-BNP was elevated in 11 (8%); troponin in 1 (1%); and CMR abnormalities in 104 (75%). Isolated pericarditis was diagnosed in 4 (3%) participants, myopericarditis in 15 (11%) and isolated myocarditis in 36 (26%). Participants diagnosed by RT-PCR were more likely to still present symptoms than participants diagnosed by serology (73 [71%] vs 18 [50%]; p=0.027); nonetheless, the prevalence of pericarditis or myocarditis was high in both groups (44 [43%] vs 11 [31%]; p=0.238). Most participants (101 [73%]) showed altered immune cell counts in blood, particularly decreased eosinophil (37 [27%]; p<0.001) and increased CD4-CD8-/loTαβ-cell numbers (24 [17%]; p<0.001). Pericarditis was associated with elevated CD4-CD8-/loTαβ-cell numbers (p=0.011), while participants diagnosed with myopericarditis or myocarditis had lower (p<0.05) plasmacytoid dendritic cell, NK-cell and plasma cell counts and lower anti-SARS-CoV-2-IgG antibody levels (p=0.027).

Conclusions Pericarditis and myocarditis with clinical stability are frequent long after SARS-CoV-2 infection, even in presently asymptomatic subjects. These observations will probably apply to the general population infected and may indicate that cardiac sequelae might occur late in association with an altered (delayed) innate and adaptative immune response.

The trial is registered with ClinicalTrials.gov, number NCT04413071

Evidence before this study Very little evidence exists describing long cardiac sequelae after SARS-CoV-2 infection. Although pericarditis and myocarditis are the two most frequent cardiac manifestations observed after a viral infection, as of May 13, 2020, the peer-reviewed literature was limited to isolated case reports of myocarditis and pericarditis during the COVID-19 hospitalization phase and to a retrospective observation in 26 recovered patients with COVID-19 pneumonia presenting cardiac complaints during hospitalization, revealing the presence of myocardial oedema in 14 (54%) patients and late gadolinium enhancement in 8 (31%) patients. These small size case series, limited to hospitalized RT-PCR patients with COVID-19 pneumonia, are insufficient to generalize conclusions about the true prevalence of pericardial and myocardial long involvement after SARS-CoV-2 infection. In addition, no study has investigated the immunological consequences of SARS-CoV-2 infection in the settings of pericarditis and myocarditis.

Added value of this study To our knowledge, this is the largest cohort of subjects (N=139) —even for other common viruses— with clinical, electrocardiographic, laboratory and CMR imaging evaluations, to assess pericardial and myocardial involvements after SARS-CoV-2 infection. The strength of this study is the addition of non-hospitalized participants and also the inclusion of participants diagnosed of past SARS-CoV-2 infection through serology. Contrary to previous studies, women are well represented. We found a prevalence of pericarditis or myocarditis up to 40% cases; pericarditis coexisted with some degree of concurrent myocardial inflammation in 11% cases. Study participants who were previously hospitalized for COVID-19 pneumonia and patients who received antiviral (hydroxychloroquine, lopinavir-ritonavir) or anti-inflammatory (high-dose glucocorticoids and anti-interleukin treatments) treatments, and who were on chronic drug treatment with statins, were less likely to develop pericarditis or myocarditis. The clinical assessment of the participants showed clinical stability without any patient presenting severe pericardial effusion, heart failure or left ventricular dysfunction. We provide new data on seropositive subjects; although RT-PCR participants were more likely to still present symptoms than participants diagnosed by serology, the prevalence of pericarditis, myocarditis or myocarditis, almost three months after the initial viral prodrome, was high in both groups. In-depth investigation of the distribution of multiple major and minor populations of immune cells in blood showed high frequency of altered immune profiles after SARS-CoV-2 infection. The altered immune cell profiles identified partially mimic abnormalities previously reported during active infection together with others described here for the first time, with unique patterns associated with pericardial and/or myocardial injury. Nonetheless, we also described altered immune profiles in participants without pericardial and myocardial manifestations. Whether these later alterations are due to persistence of tissue damage in other organs affected by SARS-CoV-2, such as the lung, or they reflect normal post-infection immune recovery mechanisms, remains to be investigated.

Implications of all the available evidence At present, there is much interest in the long-term sequelae of COVID-19. It is intriguing that pericarditis and myocarditis were observed so long after SARS-CoV-2 infection and also in some presently asymptomatic subjects, in association with notably altered immune cell profiles in blood. These observations will probably apply to the general population infected and may indicate that cardiac sequelae might occur late, paving the way for a better understanding the immune mechanisms involved. Thus, our study may have health-care consequences given the widespread diagnosis of SARS-CoV-2 infection in population-based seroprevalence studies.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04413071

Funding Statement

This study was supported by CIBERCV (CB16/11/00374), CIBERONC (CB16/12/00400) and the COV20/00386 grant from the Instituto de Salud Carlos III and FEDER, Ministerio de Ciencia e Innovacion, Madrid, Spain.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional approval (2020/05/490) for the study was provided by the University Hospital of Salamanca Ethics Committee

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • On behalf of the CCC (“Cardiac Covid-19 health Care workers”) investigators (see in Supplementary Appendix)

Data Availability

The deindentification data in this study will be shared upon request and approval will be designated by a data access committee. The data access committee comprises four authors and there is no restriction to data access.

  • Abbreviations

    CMR
    cardiac magnetic resonance
    CRP
    C-reactive protein
    ECG
    electrocardiogram
    ECV
    extracellular volume
    FcεRI
    high affinity IgE receptor I
    GZ
    granzyme B
    IMM
    immunemonitoring
    LGE
    late gadolinium enhancement
    LLC
    Lake-Louise-Criteria
    LV
    left ventricle
    LST
    lymphocyte screening tube
    RT-PCR
    reverse-transcriptase-polymerase-chain-reaction
    SARS-CoV-2
    severe acute respiratory syndrome-coronavirus 2
    Th
    T-helper cells
    t-SNE
    t-distributed stochastic neighbour embedding
    T1
    map native myocardial T1-relaxation time
    T2
    map myocardial T2-relaxation time T2W
    T2
    -weighted hyperinstensity
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 14, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers
    Rocio Eiros, Manuel Barreiro-Perez, Ana Martin-Garcia, Julia Almeida, Eduardo Villacorta, Alba Perez-Pons, Soraya Merchan, Alba Torres-Valle, Clara Sánchez Pablo, David González-Calle, Oihane Perez-Escurza, Inés Toranzo, Elena Díaz-Pelaez, Blanca Fuentes-Herrero, Laura Macías-Alvarez, Guillermo Oliva-Ariza, Quentin Lecrevisse, Rafael Fluxa, Jose L Bravo-Grande, Alberto Orfao, Pedro L Sanchez
    medRxiv 2020.07.12.20151316; doi: https://doi.org/10.1101/2020.07.12.20151316
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers
    Rocio Eiros, Manuel Barreiro-Perez, Ana Martin-Garcia, Julia Almeida, Eduardo Villacorta, Alba Perez-Pons, Soraya Merchan, Alba Torres-Valle, Clara Sánchez Pablo, David González-Calle, Oihane Perez-Escurza, Inés Toranzo, Elena Díaz-Pelaez, Blanca Fuentes-Herrero, Laura Macías-Alvarez, Guillermo Oliva-Ariza, Quentin Lecrevisse, Rafael Fluxa, Jose L Bravo-Grande, Alberto Orfao, Pedro L Sanchez
    medRxiv 2020.07.12.20151316; doi: https://doi.org/10.1101/2020.07.12.20151316

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (430)
    • Allergy and Immunology (754)
    • Anesthesia (221)
    • Cardiovascular Medicine (3287)
    • Dentistry and Oral Medicine (363)
    • Dermatology (277)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
    • Epidemiology (13355)
    • Forensic Medicine (19)
    • Gastroenterology (898)
    • Genetic and Genomic Medicine (5144)
    • Geriatric Medicine (481)
    • Health Economics (782)
    • Health Informatics (3263)
    • Health Policy (1140)
    • Health Systems and Quality Improvement (1189)
    • Hematology (429)
    • HIV/AIDS (1017)
    • Infectious Diseases (except HIV/AIDS) (14619)
    • Intensive Care and Critical Care Medicine (912)
    • Medical Education (476)
    • Medical Ethics (126)
    • Nephrology (522)
    • Neurology (4916)
    • Nursing (262)
    • Nutrition (725)
    • Obstetrics and Gynecology (882)
    • Occupational and Environmental Health (795)
    • Oncology (2518)
    • Ophthalmology (723)
    • Orthopedics (280)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (542)
    • Pediatrics (1299)
    • Pharmacology and Therapeutics (549)
    • Primary Care Research (556)
    • Psychiatry and Clinical Psychology (4202)
    • Public and Global Health (7494)
    • Radiology and Imaging (1704)
    • Rehabilitation Medicine and Physical Therapy (1010)
    • Respiratory Medicine (980)
    • Rheumatology (479)
    • Sexual and Reproductive Health (497)
    • Sports Medicine (424)
    • Surgery (547)
    • Toxicology (72)
    • Transplantation (235)
    • Urology (205)